<b>Efficacy and safety of mazdutide in Chinese patients with type 2 diabetes: A </b><b>randomized, double-blind, placebo-controlled phase 2 trial</b>
Bo Zhang(Shanghai Jiao Tong University), Wenying Yang(China-Japan Friendship Hospital), Linong Ji(Peking University), Dexue Liu(Xi'an Shiyou University), Hongwei� Jiang(First Affiliated Hospital of Henan University of Science and Technology), Shenglian Gan(The First People's Hospital of Changde), Ting Yu, Jianhua Ma(Sun Yat-sen University), Lei Qian, Shandong Ye, Jianjun Yi, Guixia Wang(Jilin University), Li Li, Juan Sun(Anhui Provincial Hospital), Xin Zhang(Sichuan Cancer Hospital), Haoyu Li(Qingdao University), Zhifeng Cheng(Harbin Medical University), Pei An(Peking University), Ping Jin, Ji Chen, Xiaoyun Wang, Guoqing Ma(First Affiliated Hospital of Heilongjiang University of Chinese Medicine), Bimin Shi(Soochow University), Qingyang Ma, Huan Deng(Nanchang University), Xuejiang Gu(Shanghai Jiao Tong University)
Cited by 0
Related Papers
Prevalence of Diabetes among Men and Women in China
|New England Journal of Medicine|2010|3.1k
Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in china
|Annals of Neurology|2011|507